7th Annual Biorepositories and Sample Management Conference
September 8 - 10, 2014 - Boston NY USIIR USA
klentini@iirusa.com
Phone:+001 646-895-7316
Attend the 7th Annual Biorepositories and Sample Management Conference to examine the industry's most pressing topics, benchmark best practices with your peers and ultimately learn how to maximize the value of your biospecimens through quality-driven biobanking. This year, the theme is quality, and how the quality of your samples can determine whether you will be forced to repeat clinical trials or reproduce their results as well as the potential fallout from adverse situations. Given the diversity of biobanks in the US, from academic institutions to research institutes and hospitals, any efforts at creating regulations or governing rules for them will require more than a "one-size-fits-all" model. Explore key topics: Next-Gen Sequencing: Enrich quality control and sample integrity with case study insights into sample storage, building a comprehensive multidisciplinary biorepository and core molecular laboratory quality program, performance metrics and more. Informed Consent:Drive positive patient outcomes through an understanding of new regulatory, global and ethical updates through a new hands-on workshop. Increase Your Global Footprint: Overcome country-specific collection, reporting, and return requirements. Plus, get a look into setting up a biorepository in Latin America presented by Baylor College of Medicine. Collaboration for Sample Quality: Case study insights from Pfizer, GlaxoSmithKline, Takeda to optimize your in-house and outsourced operations to maximize resources and minimize costs. Management of Biosample Data: Deep dives into new technology and innovative sample management projects presented by GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Don't miss out on the ultimate peer-exchange event where you can turn knowledge into actionable insights! Join 150+ sample management leaders to share real-time breakthroughs and opportunities in biospecimen management — we're all in this together! Time: 9:00 am - 5:00 pm URLs: Website: http://atnd.it/12081-4 Twitter: http://atnd.it/12081-3 Inquiries: http://atnd.it/12081-2 Website: http://atnd.it/12081-0 Price: Pharma, Biorepositories, Service Providers Main Conference Only: $1,595-$2,195 Pharma, Biorepositories, Service Providers Main Conference Plus Pre-Con Day : $2,195-$2,795 Academic & Government Main Conference Only: $995-$1,095 Academic & Government Main Conference Plus Pre-Con Day : $1,595-$1,695 Speakers: Jim Andahazy, Pr. Sample Strategy Analyst, Bristol Myers Squibb; Astrid Margossian, Baylor College of Medicine, Breast Center Buenos Aires; Sherilyn Sawyer, Scientific Director, BWH/Harvard Cohorts Biorepository; Lori Ball, COO, BioStorage Technologies; Joseph Meidling, Director Clinical Research, Clinical PGx and Specimen Management, Merck; Kathryn Shea, Vice President, Bioservices, Precision Bioservices; Lisa Miranda, President & CEO, Biobusiness Consulting Inc.; Vinagolu Rajasekhar, Memorial Sloan-Kettering Cancer Center; Steve Kelly, BioBank Lead, AstraZeneca; Melissa Rawley-Payne, Director, Head of BioBank, Pfizer; Debra Reinhard, Director, Clinical Sample Strategy & Operations, Bristol-Myers Squibb; Angen Liu, Director, Specimen Accessioning Core, Johns Hopkins University School of Medicine Venue details: Courtyard Boston Downtown, 275 Tremont Street, Boston, 02116, United States